OVA Conjugated Leukemia Inhibitory Factor (LIF)
CDF; D-FACTOR; HILDA; MLPLI; Cholinergic Differentiation Factor; Differentiation-Stimulating Factor; Melanoma-Derived LPL Inhibitor; Emfilermin
- Product No.UCPA085Mi21
- Organism Species Same name, Different species.
- SourceProtein conjugation
- Original Molecular Mass3000.0DA
- Buffer FormulationPBS, pH7.4.
- TraitsFreeze-dried powder
- Purity> 90%
- Isoelectric Pointn/a
-
Applications
Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein. - Download n/a
- UOM 10µg50µg 200µg 1mg 5mg
-
FOB
US$
For more details, please contact local distributors!US$
For more details, please contact local distributors! US$
For more details, please contact local distributors! US$
For more details, please contact local distributors! US$
For more details, please contact local distributors!
-
Packages (Simulation)
-
Packages (Simulation)
-
ISO9001: 2008, ISO13485: 2003 Registered
FORMULA of the OVA Conjugated Leukemia Inhibitory Factor (LIF)
USAGE of the OVA Conjugated Leukemia Inhibitory Factor (LIF)
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE of the OVA Conjugated Leukemia Inhibitory Factor (LIF)
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY of the OVA Conjugated Leukemia Inhibitory Factor (LIF)
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
INCREMENT SERVICES
Related products
| Catalog No. | Organism species: | Applications (RESEARCH USE ONLY!) |
| UCPA085Mi21 | OVA Conjugated Leukemia Inhibitory Factor (LIF) | Immunogen; SDS-PAGE; WB. |
GUESTBOOK